Viewing Study NCT05289167


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2025-12-25 @ 11:08 PM
Study NCT ID: NCT05289167
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-12-27
First Post: 2022-03-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)
Sponsor: Northwell Health
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module